Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHA:600196)
22.73
+1.52 (7.17%)
Jun 29, 2026, 3:00 PM CST
Shanghai Fosun Pharmaceutical (Group) Employees
Shanghai Fosun Pharmaceutical (Group) had 40,603 employees as of December 31, 2025. The number of employees increased by 46 or 0.11% compared to the previous year.
Employees
40,603
Change (1Y)
46
Growth (1Y)
0.11%
Revenue / Employee
1.04M CNY
Profits / Employee
85.62K CNY
Market Cap
51.58B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Huadong Medicine | 19,095 |
| China Resources Sanjiu Medical & Pharmaceutical | 30,304 |
| Shenzhen Salubris Pharmaceuticals | 4,087 |
| Yunnan Baiyao Group Co.,Ltd | 9,286 |
| Beijing Tongrentang | 17,284 |
| Zhejiang NHU Company | 11,508 |
| Dong-E-E-Jiao | 4,345 |
| Humanwell Healthcare (Group) | 17,153 |
Shanghai Fosun Pharmaceutical (Group) News
- 2 months ago - Shanghai Fosun Pharmaceutical (Group) Quarterly report: Q1 2026 - Filings
- 3 months ago - Shanghai Fosun Pharmaceutical (Group) Annual report: H2 2025 - Filings
- 8 months ago - Shanghai Fosun Pharmaceutical (Group) Quarterly report: Q3 2025 - Filings
- 8 months ago - Shanghai Fosun Pharmaceutical (Group) Slides: Q3 2025 - Filings
- 10 months ago - Shanghai Fosun Pharmaceutical (Group) Quarterly report: H1 2025 - Filings
- 10 months ago - Shanghai Fosun Pharmaceutical (Group) Slides: H1 2025 - Filings
- 3 years ago - Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse - Reuters
- 3 years ago - Syneos Health partners with Fosun Pharma USA to launch serplulimab - TheFly